Armonie Wilson, who has alopecia, used to think nobody should see her without a wig. Now, she models without one.

The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...

Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its way into Europe and wants to build more personalized drugs for its ...

Hims & Hers Health sees some volatility with revenue growth, 38% subscriber increase, and promising telehealth market demand. See why I rate HIMS stock a Buy.

Hers doesn't offer women as many prescription options as its brother company, Hims, which caters to men. Minoxidil is the go-to treatment for many clinicians, but medications like spironolactone ...

The global Black hair care industry was worth about $3.2 billion in 2023, according to market.us, and Black women spend six times more on hair care than other ethnicities.

Start your journey to fuller-looking, thicker hair with a range of effective hair loss treatment options available through Hims & Hers - it's 100% online. No doctor's office visit needed ...

Andrew Dudum, cofounder of San Francisco-based online pharmacy Hims & Hers, a seller of wellness products for men and women – including hair loss and erectile dysfunction pills – is now a ...

Founded in 2017, Hims & Hers initially focused on men’s health, selling erectile dysfunction medications and hair loss treatments. The following year, it expanded into women’s health and added ...

Yet GLP-1 drugs represented less than 20% of Hims & Hers revenue in 2024 while hair-loss products for both men and women enjoyed phenomenal growth. In Q4, Hims Derm saw 55% year-over-year ...